Oligometastatic prostate cancer: definitions, clinical outcomes and treatment considerations
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oligometastatic prostate cancer: definitions, clinical outcomes and treatment considerations
Authors
Keywords
-
Journal
Nature Reviews Urology
Volume 14, Issue 1, Pages 15-25
Publisher
Springer Nature
Online
2016-10-11
DOI
10.1038/nrurol.2016.175
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 68Ga-PSMA has a high detection rate of prostate cancer recurrence outside the prostatic fossa in patients being considered for salvage radiation treatment
- (2016) Pim J. van Leeuwen et al. BJU INTERNATIONAL
- New Clinical Indications for 18 F/ 11 C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature
- (2016) Laura Evangelista et al. EUROPEAN UROLOGY
- Is There Another Bite of the Cherry? The Case for Radical Local Therapy for Oligometastatic Disease in Prostate Cancer
- (2016) Vincent Khoo EUROPEAN UROLOGY
- Treatment of the Primary Tumor in Metastatic Prostate Cancer: Current Concepts and Future Perspectives
- (2016) Christopher E. Bayne et al. EUROPEAN UROLOGY
- A Multi-institutional Analysis of Perioperative Outcomes in 106 Men Who Underwent Radical Prostatectomy for Distant Metastatic Prostate Cancer at Presentation
- (2016) Prasanna Sooriakumaran et al. EUROPEAN UROLOGY
- Progression-free Survival Following Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Treatment-naive Recurrence: A Multi-institutional Analysis
- (2016) Piet Ost et al. EUROPEAN UROLOGY
- Prospective Study Evaluating Na18F PET/CT in Predicting Clinical Outcomes and Survival in Advanced Prostate Cancer
- (2016) A. B. Apolo et al. JOURNAL OF NUCLEAR MEDICINE
- Prostate Cancer, Version 1.2016
- (2016) James L. Mohler et al. Journal of the National Comprehensive Cancer Network
- Current use of PSMA–PET in prostate cancer management
- (2016) Tobias Maurer et al. Nature Reviews Urology
- Failure-Free Survival and Radiotherapy in Patients With Newly Diagnosed Nonmetastatic Prostate Cancer
- (2016) Nicholas D. James et al. JAMA Oncology
- Does Radiotherapy for the Primary Tumor Benefit Prostate Cancer Patients with Distant Metastasis at Initial Diagnosis?
- (2016) Yeona Cho et al. PLoS One
- Seeing and Not Believing: Oligometastases and the Future of Metastatic Prostate Cancer
- (2015) Eric A. Klein EUROPEAN UROLOGY
- Patterns of Declining Use and the Adverse Effect of Primary Androgen Deprivation on All-cause Mortality in Elderly Men with Prostate Cancer
- (2015) Jesse D. Sammon et al. EUROPEAN UROLOGY
- Impact of the Site of Metastases on Survival in Patients with Metastatic Prostate Cancer
- (2015) Giorgio Gandaglia et al. EUROPEAN UROLOGY
- Metastasis-directed Therapy of Regional and Distant Recurrences After Curative Treatment of Prostate Cancer: A Systematic Review of the Literature
- (2015) Piet Ost et al. EUROPEAN UROLOGY
- Identifying Optimal Candidates for Local Treatment of the Primary Tumor Among Patients Diagnosed with Metastatic Prostate Cancer: A SEER-based Study
- (2015) Nicola Fossati et al. EUROPEAN UROLOGY
- Androgen Deprivation With or Without Radiation Therapy for Clinically Node-Positive Prostate Cancer
- (2015) Chun Chieh Lin et al. JNCI-Journal of the National Cancer Institute
- Radical Prostatectomy or External Beam Radiation Therapy vs No Local Therapy for Survival Benefit in Metastatic Prostate Cancer: A SEER-Medicare Analysis
- (2015) Raj Satkunasivam et al. JOURNAL OF UROLOGY
- Cytoreductive Radical Prostatectomy in Patients with Prostate Cancer and Low Volume Skeletal Metastases: Results of a Feasibility and Case-Control Study
- (2015) Axel Heidenreich et al. JOURNAL OF UROLOGY
- The evolutionary history of lethal metastatic prostate cancer
- (2015) Gunes Gundem et al. NATURE
- Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
- (2015) Christopher J. Sweeney et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- The biology and treatment of oligometastatic cancer
- (2015) Diane K. Reyes et al. Oncotarget
- Androgen Deprivation With or Without Radiation Therapy for Clinically Node-Positive Prostate Cancer
- (2015) Chun Chieh Lin et al. JNCI-Journal of the National Cancer Institute
- Surveillance or metastasis-directed Therapy for OligoMetastatic Prostate cancer recurrence (STOMP): study protocol for a randomized phase II trial
- (2014) Karel Decaestecker et al. BMC CANCER
- Prognostic impact of definitive local therapy of the primary tumor in men with metastatic prostate cancer at diagnosis: A population-based, propensity score analysis
- (2014) Samuel Antwi et al. Cancer Epidemiology
- Role of Radical Prostatectomy in Metastatic Prostate Cancer: Data from the Munich Cancer Registry
- (2014) Christian Gratzke et al. EUROPEAN UROLOGY
- Combining Enzalutamide with Abiraterone, Prednisone, and Androgen Deprivation Therapy in the STAMPEDE Trial
- (2014) Gerhardt Attard et al. EUROPEAN UROLOGY
- Patterns of Care Among Patients Receiving Radiation Therapy for Bone Metastases at a Large Academic Institution
- (2014) Susannah G. Ellsworth et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- The Impact of Definitive Local Therapy for Lymph Node-Positive Prostate Cancer: A Population-Based Study
- (2014) Chad G. Rusthoven et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial
- (2014) Eugene D Kwon et al. LANCET ONCOLOGY
- Prostate Cancer Treatment and Survival
- (2014) Cathy J. Bradley et al. MEDICAL CARE
- MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
- (2014) Thomas Powles et al. NATURE
- Establishment of a new prostate cancer multidisciplinary clinic: Format and initial experience
- (2014) Debasish Sundi et al. PROSTATE
- Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence
- (2014) Karel Decaestecker et al. Radiation Oncology
- Molecular Imaging of Urogenital Diseases
- (2014) Steve Y. Cho et al. SEMINARS IN NUCLEAR MEDICINE
- Ecological Therapy for Cancer: Defining Tumors Using an Ecosystem Paradigm Suggests New Opportunities for Novel Cancer Treatments
- (2014) Kenneth J. Pienta et al. Translational Oncology
- A Comprehensive Review of Contemporary Role of Local Treatment of the Primary Tumor and/or the Metastases in Metastatic Prostate Cancer
- (2014) Fouad Aoun et al. Biomed Research International
- Androgen deprivation and high-dose radiotherapy for oligometastatic prostate cancer patients with less than five regional and/or distant metastases
- (2013) Ulrike Schick et al. ACTA ONCOLOGICA
- Effect of Age, Tumor Risk, and Comorbidity on Competing Risks for Survival in a U.S. Population–Based Cohort of Men With Prostate Cancer
- (2013) Timothy J. Daskivich et al. ANNALS OF INTERNAL MEDICINE
- Primary treatment of the prostate improves local palliation in men who ultimately develop castrate-resistant prostate cancer
- (2013) Andy C.M. Won et al. BJU INTERNATIONAL
- Spine metastases in prostate cancer: comparison of technetium-99m-MDP whole-body bone scintigraphy, [18F]choline positron emission tomography(PET)/computed tomography (CT) and [18F]NaF PET/CT
- (2013) Mads H. Poulsen et al. BJU INTERNATIONAL
- EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer
- (2013) Axel Heidenreich et al. EUROPEAN UROLOGY
- Might Men Diagnosed with Metastatic Prostate Cancer Benefit from Definitive Treatment of the Primary Tumor? A SEER-Based Study
- (2013) Stephen H. Culp et al. EUROPEAN UROLOGY
- EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013
- (2013) Axel Heidenreich et al. EUROPEAN UROLOGY
- Extracranial Oligometastases: A Subset of Metastases Curable With Stereotactic Radiotherapy
- (2013) Kimberly S. Corbin et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
- (2013) Omid Hamid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic factors influencing prostate cancer-specific survival in non-castrate patients with metastatic prostate cancer
- (2013) Piet Ost et al. PROSTATE
- Palliative pelvic radiotherapy of symptomatic incurable prostate cancer – A systematic review
- (2013) Marte Grønlie Cameron et al. RADIOTHERAPY AND ONCOLOGY
- Stereotactic body radiation therapy in the treatment of oligometastatic prostate cancer
- (2013) Kamran A. Ahmed et al. Frontiers in Oncology
- Salvage Stereotactic Body Radiotherapy for Patients With Limited Prostate Cancer Metastases: Deferring Androgen Deprivation Therapy
- (2012) Patrick Berkovic et al. Clinical Genitourinary Cancer
- Positive Surgical Margin and Perioperative Complication Rates of Primary Surgical Treatments for Prostate Cancer: A Systematic Review and Meta-Analysis Comparing Retropubic, Laparoscopic, and Robotic Prostatectomy
- (2012) Ashutosh Tewari et al. EUROPEAN UROLOGY
- Cytoreduction surgery reduces systemic myeloid suppressor cell populations and restores intratumoral immunotherapy effectiveness
- (2012) Jarrod D Predina et al. Journal of Hematology & Oncology
- An overview of the objectives of and the approaches to propensity score analyses
- (2011) Georg Heinze et al. EUROPEAN HEART JOURNAL
- MicroRNA Expression Characterizes Oligometastasis(es)
- (2011) Yves A. Lussier et al. PLoS One
- Safety and feasibility of image-guided robotic radiosurgery for patients with limited bone metastases of prostate cancer
- (2011) Alexander Muacevic et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumor cytoreduction results in better response to androgen ablation—a preliminary report of palliative transurethral resection of the prostate in metastatic hormone sensitive prostate cancer
- (2010) Xiao-Jian Qin et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Review of major adverse effects of androgen-deprivation therapy in men with prostate cancer
- (2009) Lockwood G. Taylor et al. CANCER
- Tumor Self-Seeding by Circulating Cancer Cells
- (2009) Mi-Young Kim et al. CELL
- Potential Benefits of Intermittent Androgen Suppression Therapy in the Treatment of Prostate Cancer: A Systematic Review of the Literature
- (2009) Per-Anders Abrahamsson EUROPEAN UROLOGY
- Gene signatures of pulmonary metastases of renal cell carcinoma reflect the disease-free interval and the number of metastases per patient
- (2009) Daniela Wuttig et al. INTERNATIONAL JOURNAL OF CANCER
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started